Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 Feb;63(2):230–238. doi: 10.1172/JCI109294

Adrenergic Modulation of Pancreatic A, B, and D Cells

α-ADRENERGIC SUPPRESSION AND β-ADRENERGIC STIMULATION OF SOMATOSTATIN SECRETION, α-ADRENERGIC STIMULATION OF GLUCAGON SECRETION IN THE PERFUSED DOG PANCREAS

Ellis Samols 1,2,3, Gordon C Weir 1,2,3
PMCID: PMC371944  PMID: 34627

Abstract

The effects of adrenergic substances on pancreatic insular secretions were studied in a completely isolated canine pancreas with exclusion of the duodenum from the perfusion circuit. To ensure adequate blockade, blockers were infused before agonists. A dose range of β-receptor blockade was tested, and putative α-adrenergic effects were confirmed by combined α- and β-adrenergic receptor blockade.

β-Adrenergic agonism (2 ng/ml isoproterenol) induced a mean integrated increase of 79±20% in somatostatin secretion, whereas glucagon and insulin secretion were increased by 185±45 and 495±146%, respectively. The stimulations of D, A, and B cells were abolished by propranolol.

α-Adrenergic agonism (10 ng/ml epinephrine) after β-adrenergic blockade) moderately decreased somatostatin (−37±7%) secretion, moderately increased glucagon (91±19%), and markedly decreased insulin (−85±3%) release. Similar effects on D-, A-, and B-cell secretion were induced with 2 ng/ml epinephrine or 10 ng/ml norepinephrine after β-adrenergic blockade. The α-adrenergic effects on the D and A cell were abolished by either phentolamine or by phenoxybenzamine.

This study showed that there are indeed α-adrenergic receptors on A cells and that the secretion of glucagon, a “stress” hormone, was stimulated either by α- or β-adrenergic receptor agonism. D-cell secretion, like that of the B cell, was inhibited by α-adrenergic agonism and was stimulated by β-adrenergic agonism. However, β-adrenergic-induced changes in D-cell secretion were smaller in magnitude than those of B-cell secretion.

Full text

PDF
230

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Furchgott R. F. Pharmacological characteristics of adrenergic receptors. Fed Proc. 1970 Jul-Aug;29(4):1352–1361. [PubMed] [Google Scholar]
  2. Furchgott R. F. The pharmacological differentiation of adrenergic receptors. Ann N Y Acad Sci. 1967 Feb 10;139(3):553–570. doi: 10.1111/j.1749-6632.1967.tb41229.x. [DOI] [PubMed] [Google Scholar]
  3. Gerich J. E., Charles M. A., Grodsky G. M. Regulation of pancreatic insulin and glucagon secretion. Annu Rev Physiol. 1976;38:353–388. doi: 10.1146/annurev.ph.38.030176.002033. [DOI] [PubMed] [Google Scholar]
  4. Gerich J. E., Langlois M., Noacco C., Schneider V., Forsham P. H. Adrenergic modulation of pancreatic glucagon secretion in man. J Clin Invest. 1974 May;53(5):1441–1446. doi: 10.1172/JCI107692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
  6. Iversen J. Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas. J Clin Invest. 1973 Sep;52(9):2102–2116. doi: 10.1172/JCI107395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Iversen J., Miles D. W. Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes. 1971 Jan;20(1):1–9. doi: 10.2337/diab.20.1.1. [DOI] [PubMed] [Google Scholar]
  8. Langer S. Z., Trendelenburg U. The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J Pharmacol Exp Ther. 1969 May;167(1):117–142. [PubMed] [Google Scholar]
  9. Pagliara A. S., Stillings S. N., Hover B., Martin D. M., Matschinsky F. M. Glucose modulation of amino acid-induced glucagon and insulin release in the isolated perfused rat pancreas. J Clin Invest. 1974 Oct;54(4):819–832. doi: 10.1172/JCI107822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Patel Y. C., Reichlin S. Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat. Endocrinology. 1978 Feb;102(2):523–530. doi: 10.1210/endo-102-2-523. [DOI] [PubMed] [Google Scholar]
  11. Polak J. M., Pearse A. G., Grimelius L., Bloom S. R. Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet. 1975 May 31;1(7918):1220–1222. doi: 10.1016/s0140-6736(75)92198-4. [DOI] [PubMed] [Google Scholar]
  12. Potter L. T. Uptake of propranolol by isolated guinea-pig atria. J Pharmacol Exp Ther. 1967 Jan;155(1):91–100. [PubMed] [Google Scholar]
  13. Samols E., Weir G. C., Ramseur R., Day J. A., Patel Y. C. Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyper- and hypoglycemic sulfonamides. Metabolism. 1978 Sep;27(9 Suppl 1):1219–1221. doi: 10.1016/0026-0495(78)90046-x. [DOI] [PubMed] [Google Scholar]
  14. Walter R. M., Dudl R. J., Palmer J. P., Ensinck J. W. The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man. J Clin Invest. 1974 Nov;54(5):1214–1220. doi: 10.1172/JCI107864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Weir G. C., Goltsos P. C., Steinberg E. P., Patel Y. C. High concentration of somatostatin immunoreactivity in chicken pancreas. Diabetologia. 1976 May;12(2):129–132. doi: 10.1007/BF00428977. [DOI] [PubMed] [Google Scholar]
  16. Williams L. T., Mullikin D., Lefkowitz R. J. Identification of alpha-adrenergic receptors in uterine smooth muscle membranes by [3H]dihydroergocryptine binding. J Biol Chem. 1976 Nov 25;251(22):6915–6923. [PubMed] [Google Scholar]
  17. Woods S. C., Porte D., Jr Neural control of the endocrine pancreas. Physiol Rev. 1974 Jul;54(3):596–619. doi: 10.1152/physrev.1974.54.3.596. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES